Answers are grounded in this paper and cite their sources.
The findings indicate a potential beneficial role of T-PEMF therapy as an augmentation treatment to ongoing pharmacotherapy in treatment-resistant depression.
No takes yet. Share an insight, caveat, or question.
Larsen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: